Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Abstract
Abuse of the dissociative anesthetic ketamine can lead to a syndrome indistinguishable from schizophrenia. In animals, repetitive exposure to this N -methyl- d -aspartate–receptor antagonist induces the dysfunction of a subset of cortical fast-spiking inhibitory interneurons, with loss of expression of parvalbumin and the γ-aminobutyric acid–producing enzyme GAD67. We show here that exposure of mice to ketamine induced a persistent increase in brain superoxide due to activation in neurons of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Decreasing superoxide production prevented the effects of ketamine on inhibitory interneurons in the prefrontal cortex. These results suggest that NADPH oxidase may represent a novel target for the treatment of ketamine-induced psychosis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Redox dysregulation severely impacts the development of PV+ fast spiking interneurons.
“Interestingly, redox dysregulation severely impacts the development of PV+ fast spiking interneurons 81,83”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [83]
High metabolic demands make fast-spiking interneurons particularly vulnerable to oxidative stress.
“High metabolic demands render fast-spiking interneurons particularly vulnerable to oxidative stress (23).”
From Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons (2015) · cites this paper as [23]
Animal models with globally disrupted redox state show defects in fast-spiking interneurons.
“Animal models of globally disrupted redox state exhibit defects in fast-spiking interneurons (16, 23, 25)”
From Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons (2015) · cites this paper as [23]
High metabolic requirements of fast-spiking PV interneurons may readily generate reactive oxygen species when antioxidant systems are impaired, leading to breakdown of PNNs.
“The high metabolic requirements of the fast-spiking PV-interneuron (23) may readily generate reactive oxygen species when their antioxidant systems are impaired, leading to the breakdown of PNNs themselves (Figure 2C,D) (53).”
From Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons (2015) · cites this paper as [23]
NMDAR blockade in adults disrupts excitatory/inhibitory balance in cortical circuits, affecting parvalbumin interneurons and neuronal network activity.
“Numerous studies show that NMDAR blockade in adults disrupts excitatory/inhibitory balance in cortical circuits, affecting PVI (Behrens et al., 2007) and neuronal network activity (Carlen et al., 2012; Homayoun and Moghaddam, 2007; Kocsis et al., 2013; Korotkova et al., 2010; Lazarewicz et al., 2010).”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Behrens et al., 2007
Superoxide overproduction by NADPH oxidase is deleterious to parvalbumin interneurons, and NOX inhibition prevents the parvalbumin interneuron impairment induced by social isolation.
“Furthermore, superoxide overproduction by NADPH oxidase (NOX) is also deleterious to PVI (Behrens et al., 2007), and NOX inhibition prevents the PVI impairment induced by social isolation (Schiavone et al., 2009).”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Behrens et al., 2007
Animal models of schizophrenia show reduced PV fluorescence per cell in prelimbic regions.
“Animal models that mimic schizophrenia replicate the loss of PV-INs in the hippocampus [6,14,15], and show a loss of PV fluorescence per cell in prelimbic regions [16].”
From Parvalbumin interneuron vulnerability and brain disorders (2021) · cites this paper as [16]
This PV-IN injury is linked to IL-6-mediated, Nox2-dependent NADPH oxidase activation and superoxide production.
“This injury is connected to IL-6mediated Nox2-dependent NADPH oxidase activation and production of superoxide [16,95].”
From Parvalbumin interneuron vulnerability and brain disorders (2021) · cites this paper as [16]
PV-INs receive the greatest excitatory input of any inhibitory neuron population in the cortex, placing them under intense stress.
“Indeed, PV-INs receive the greatest excitatory input of any population of inhibitory neurons in the cortex, which puts them under intense stress [16,80].”
From Parvalbumin interneuron vulnerability and brain disorders (2021) · cites this paper as [16]
PV-INs have extraordinary energy requirements to support high metabolic activity and to protect against significant glutamatergic stress.
“PV-INs have extraordinary energy requirements to support a high metabolic activity and to protect against significant glutamatergic stress [16,80,81].”
From Parvalbumin interneuron vulnerability and brain disorders (2021) · cites this paper as [16]
Ketamine, a pro-inflammatory stimulus, injures PV-INs in vitro and in vivo.
“For example, the NMDA receptor antagonist ketamine, a pro-inflammatory stimulus, injures PV-INs in vitro and in vivo [16,95].”
From Parvalbumin interneuron vulnerability and brain disorders (2021) · cites this paper as [16]
The oxidative stress-induced PVI deficit may also hold for other brain regions like the hippocampus, as shown in some models of schizophrenia (e.g., GCLM KO, ketamine, MAM, poly(I:C), and social defeat).
“Although our analysis focused on oxidative stress-induced PVI deficit in the prefrontal cortex, this deficit may also hold for other brain regions like the hippocampus, as shown in some models of schizophrenia (for example, GCLM KO, ketamine, MAM, poly(I:C) and social defeat.22, 37, 47, 48, 84”
From Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia (2017) · cites this paper as [37]
Redox dysregulation has successfully been targeted to protect PVIs with antioxidants/redox regulators across several animal models.
“As convergent end point, redox dysregulation has successfully been targeted to protect PVIs with antioxidants/redox regulators across several animal models.”
From Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia (2017) · cites this paper as [37]
PVIs are vulnerable to redox dysregulation/oxidative stress.
“Indeed, PVIs are vulnerable to redox dysregulation/oxidative stress.37, 38, 39, 40”
From Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia (2017) · cites this paper as [37]
Prolonged NMDA-receptor hypofunction is associated with reduced GABAergic neurotransmission.
“prolonged NMDA-receptor hypofunction is associated with reduced GABAergic neurotransmission, which has been confirmed in several studies”
From Neuronal Dynamics and Neuropsychiatric Disorders: Toward a Translational Paradigm for Dysfunctional Large-Scale Networks (2012) · cites this paper as Behrens et al., 2007
Noncompeting NMDA antagonists affect inhibitory interneuron function by altering redox mechanisms, an effect that depends on interleukin 6 and other cytokines.
“Noncompeting NMDA antagonists affect inhibitory interneuron function by altering redox mechanisms, 74 an effect that depends on interleukin 6 and other cytokines.75”
From Adolescent Onset of Cortical Disinhibition in Schizophrenia: Insights From Animal Models (2011) · cites this paper as [74]
The citation lists haven’t been fetched yet
References 136 · Cited by 585
- Authors
- Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Behrens, M. Margarita
- Dugan, Laura L.
- Venue
- Science
- Published
- 2007-12-07
- Volume
- 318
- Issue
- 5856
- Pages
- 1645-1647
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2061902128
- Cited by
- 585
- References
- 136
- Citations by year
- 2026: 17 · 2025: 15 · 2024: 22 · 2023: 11 · 2022: 19 · 2021: 26 · 2020: 25 · 2019: 29 · 2018: 26 · 2017: 37 · 2016: 42 · 2015: 41 · 2014: 42 · 2013: 43 · 2012: 50
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Anesthesia and Neurotoxicity Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- ketamine, NADPH oxidase, fast-spiking interneurons, parvalbumin, GAD67, superoxide, oxidative stress, schizophrenia, NMDA receptor antagonists, prefrontal cortex, ketamine-induced psychosis
- MeSH terms
- NADPH Oxidase 2, Acetophenones, Animals, Brain, Cells, Cultured, Enzyme Activation, Enzyme Inhibitors, Glutamate Decarboxylase, Interneurons, Ketamine, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Synaptic Transmission, Oxidation-Reduction, Parvalbumins, Superoxides, Synaptosomes, Receptors, N-Methyl-D-Aspartate, NADPH Oxidases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review